insights_auto
Outlook: 34.8% bullish·8.7% bearish
Go to analysischevron_right
GSK:NYSE
GSK plc
US$ ५०.३३
arrow_downward
-०.१६%(-०.०८०) 1D
US$ ५०.३३
०.००% (०.००)
bedtimeAfter hours
Closed: नोभेम्बर ६, १६:००:०२ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GSK...
Open
US$ ४९.०७
High
US$ ५०.७४
Low
US$ ४८.९४
Mkt. cap
१.०३ खरब
Avg. vol.
५३.५५ लाख
Volume
३१.८५ लाख
Dividend
३.६५%
Quarterly dividend
US$ ०.४६
Ex-dividend date
२०२६ अगस्ट १३
P/E ratio
१७.५२
52-wk high
US$ ६१.७०
52-wk low
US$ ४५.८०
EPS
US$ २.८७
Beta
०.२०
Shares outstanding
२.०२ अरब
No. of employees
६७ हजार
Open
US$ ४९.०७
High
US$ ५०.७४
Low
US$ ४८.९४
Mkt. cap
१.०३ खरब
Avg. vol.
५३.५५ लाख
Volume
३१.८५ लाख
Dividend
३.६५%
Quarterly dividend
US$ ०.४६
Ex-dividend date
२०२६ अगस्ट १३
P/E ratio
१७.५२
52-wk high
US$ ६१.७०
52-wk low
US$ ४५.८०
EPS
US$ २.८७
Beta
०.२०
Shares outstanding
२.०२ अरब
No. of employees
६७ हजार
News stories
From web sources and news partners
Fortune
·
१ दिन पहिले
Why HP chose GSK chief Emma Walmsley as CEO
Reuters
·
३ दिन पहिले
HP picks GSK restructuring veteran Walmsley as CEO, shares jump over 6%
Briefs Finance
·
३ दिन पहिले
HP names Emma Walmsley CEO, starts Jan 4
Yahoo Finance
·
३ दिन पहिले
HP Names Emma Walmsley as New CEO, Ending Monthlong Search
Profile
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK.
The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
About GSK plc
CEOEmma Walmsley | Emma Walmsley
Employees६६.८ हजार
Founded२००० डिसेम्बर २७
Headquarters-
SectorHealth Care
Industry-
Websitegsk.com